NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. It sells its products through own sales force, as well as independent representatives and distributors.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.9B | $3.2B | $3.3B | $3.5B | $3.6B | $3.8B |
| Gross profit | $906.0M | — | — | — | — | — |
| Operating income | $339.5M | $347.3M | $379.3M | $404.0M | $496.5M | $501.0M |
| Net income | $214.0M | $244.1M | $239.3M | $284.5M | $374.5M | $392.8M |
| Diluted EPS | $3.21 | $3.61 | $3.59 | $4.25 | $5.53 | $5.89 |
| Operating cash flow | $570.2M | $363.4M | $478.6M | $575.2M | $643.4M | $570.0M |
| Free cash flow | $324.2M | $55.5M | $168.2M | $262.9M | $366.9M | $299.6M |
| Gross margin | 30.9% | — | — | — | — | — |
| Operating margin | 11.6% | 10.8% | 11.4% | 11.6% | 13.9% | 13.3% |
| Net margin | 7.3% | 7.6% | 7.2% | 8.2% | 10.5% | 10.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $910.1M | $909.3M | $848.1M | $887.3M | $966.0M | $961.1M | $962.7M | $982.9M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $126.0M | $138.3M | $120.1M | $113.4M | $144.4M | $136.9M | $106.3M | $107.5M |
| Net income | $90.5M | $100.0M | $100.9M | $78.8M | $111.7M | $127.9M | $74.3M | $72.7M |
| Diluted EPS | $1.34 | $1.48 | $1.48 | $1.17 | $1.67 | $1.92 | $1.13 | $1.12 |
| Operating cash flow | $143.6M | $229.3M | $178.2M | $82.7M | $126.0M | $177.6M | $183.7M | $118.7M |
| Free cash flow | $75.4M | $162.7M | $112.2M | $25.9M | $62.5M | $114.3M | $96.9M | $53.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 13.8% | 15.2% | 14.2% | 12.8% | 14.9% | 14.2% | 11.0% | 10.9% |
| Net margin | 9.9% | 11.0% | 11.9% | 8.9% | 11.6% | 13.3% | 7.7% | 7.4% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-16 | FOTIADES GEORGE L | Award | 151 | $0.00 | $0.00 | filing |
| 2026-07-16 | Kampouri Monnas Giovanna | Award | 151 | $0.00 | $0.00 | filing |
| 2026-07-16 | Marey-Semper Isabel | Award | 151 | $0.00 | $0.00 | filing |
| 2026-07-16 | Matthews Candace S. | Award | 226 | $0.00 | $0.00 | filing |
| 2026-07-16 | Wunderlich Ralf K. | Award | 151 | $0.00 | $0.00 | filing |
| 2026-07-16 | Owens B Craig | Award | 151 | $0.00 | $0.00 | filing |
| 2026-07-16 | Glickman Sarah JS | Award | 151 | $0.00 | $0.00 | filing |
| 2026-07-16 | Xing Julie | Award | 151 | $0.00 | $0.00 | filing |
| 2026-07-16 | Trerotola Matthew L. | Award | 151 | $0.00 | $0.00 | filing |
| 2026-06-15 | Gandhi Aditya· CAO | Award | 2,664 | $0.00 | $0.00 | filing |
| 2026-06-09 | Prieur Marc· Segment President | Sale | 4,553 | $115.53 | $526,007.18 | filing |
| 2026-06-09 | Prieur Marc· Segment President | Sale | 447 | $116.08 | $51,887.49 | filing |
| 2026-06-04 | Vinczeller Shiela· Chief Human Resources Officer | Sale | 2,957 | $112.36 | $332,240.24 | filing |
| 2026-06-04 | Vinczeller Shiela· Chief Human Resources Officer | Sale | 385 | $113.52 | $43,705.74 | filing |
| 2026-06-04 | Vinczeller Shiela· Chief Human Resources Officer | Sale | 213 | $114.53 | $24,395.38 | filing |
| 2026-05-26 | Gong Xiangwei· President, Asia | Sale | 4,200 | $116.13 | $487,764.90 | filing |
| 2026-05-21 | Tlili Hedi· Segment President | Tax withholding | 688 | $116.50 | $80,152.00 | filing |
| 2026-05-07 | Hudson Irene Elizabeth· EVP and Chief Legal Officer | Sale | 842 | $123.45 | $103,945.57 | filing |
| 2026-05-07 | Hudson Irene Elizabeth· EVP and Chief Legal Officer | Option exercise | 842 | $111.38 | $93,781.96 | filing |
| 2026-05-07 | Hudson Irene Elizabeth· EVP and Chief Legal Officer | Sale | 422 | $123.38 | $52,066.87 | filing |
| 2026-05-06 | FOTIADES GEORGE L | Award | 1,326 | $0.00 | $0.00 | filing |
| 2026-05-06 | Trerotola Matthew L. | Award | 1,326 | $0.00 | $0.00 | filing |
| 2026-05-06 | Wunderlich Ralf K. | Award | 1,326 | $0.00 | $0.00 | filing |
| 2026-05-06 | Xing Julie | Award | 1,326 | $0.00 | $0.00 | filing |
| 2026-05-06 | Matthews Candace S. | Award | 1,552 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.